Sanofi Pasteur, the vaccine division of Sanofi-Aventis, has submitted a supplemental application to the FDA to license its influenza A/H1N1 2009 monovalent vaccine. The application requests the FDA’s evaluation of the influenza A/H1N1 2009 strain change, which is expected to expedite the licensure process for the pandemic vaccine. “Filing this application is consistent with our commitment to work collaboratively with public health officials in producing a vaccine against the influ...